Specifically, PI3K engages BCR signaling by indirectly contributing to NF-κB activity in ABC-DLBCL, whereas in GCB-DLBCL, PI3K pathway activation but not NF-κB activity is required for survival. This evidence concerns the gene PIK3CD and diffuse large B-cell lymphoma.